Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)

NCT01908556 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

3545

Enrollment

OTHER

Sponsor class

Conditions

is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.

Interventions

DRUG: Letrozole

Sponsor

Institut fuer Frauengesundheit

Collaborators

[object Object]
[object Object]